ArticleCancers2023

Combination Therapy with a Bispecific Antibody Targeting the hERG1/β1 Integrin Complex and Gemcitabine in Pancreatic Ductal Adenocarcinoma.

Tiziano Lottini et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.